Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             40 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) OHIRA, T.
2007
5 7 p. 1455-1461
artikel
2 Acute respiratory tract infections in elderly patients increase systemic levels of hemostatic proteins KELLER, T. T.
2007
5 7 p. 1567-1569
artikel
3 ANNOUNCEMENTS 2007
5 7 p. 1573
artikel
4 A proposed structural model of human protein Z LEE, C. J.
2007
5 7 p. 1558-1561
artikel
5 Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery QUINLAN, D. J.
2007
5 7 p. 1438-1443
artikel
6 Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis VAN HYLCKAMA VLIEG, A.
2007
5 7 p. 1449-1454
artikel
7 Changes in fibrinolytic activity after angiotensin II receptor blockade in therapy-resistant hypertensive patients DIELIS, A. W. J. H.
2007
5 7 p. 1509-1515
artikel
8 Clearance mechanisms of von Willebrand factor and factor VIII LENTING, P. J.
2007
5 7 p. 1353-1360
artikel
9 Controlled shedding of platelet glycoprotein (GP)VI and GPIb–IX–V by ADAM family metalloproteinases GARDINER, E. E.
2007
5 7 p. 1530-1537
artikel
10 Endothelial protein C receptor: location…with a pool! WEILER, H.
2007
5 7 p. 1391-1393
artikel
11 Essential thrombin residues for inhibition by protein C inhibitor with the cofactors heparin and thrombomodulin FORTENBERRY, Y. M.
2007
5 7 p. 1486-1492
artikel
12 Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development REPESSÉ, Y.
2007
5 7 p. 1469-1476
artikel
13 Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: physiologic and pathologic implications BAJAJ, M. S.
2007
5 7 p. 1493-1499
artikel
14 High levels of low-density lipoprotein cholesterol and triglycerides and suboptimal glycemic control predict diminished ex vivo aspirin responsiveness in patients with Type 2 diabetes 1 HOVENS, M. M. C.
2007
5 7 p. 1562-1564
artikel
15 Inhibitors, what is the risk of treatment intensity? COLLINS, P. W.
2007
5 7 p. 1380-1382
artikel
16 Is tissue factor the ‘original sin’ of clotting, or is it factor VII? RICKLES, F. R.
2007
5 7 p. 1401-1402
artikel
17 Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk? NAPOLEONE, E.
2007
5 7 p. 1462-1468
artikel
18 Mechanical prophylaxis for travellers’ thrombosis: a comparison of three interventions that promote venous outflow COPPENS, M.
2007
5 7 p. 1556-1567
artikel
19 Microsomal prostaglandin E synthase-1, which is not coupled to a particular cyclooxygenase isoenzyme, is essential for prostaglandin E2 biosynthesis in vascular smooth muscle cells CAMACHO, M.
2007
5 7 p. 1411-1419
artikel
20 Non-hematopoietic EPCR regulates the coagulation and inflammatory responses during endotoxemia ZHENG, X.
2007
5 7 p. 1394-1400
artikel
21 Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations COPPENS, M.
2007
5 7 p. 1444-1448
artikel
22 Platelet integrin αIIbβ3: activation mechanisms MA, Y.-Q.
2007
5 7 p. 1345-1352
artikel
23 Platelets express three different splice variants of ApoER2 that are all involved in signaling PENNINGS, M. T. T.
2007
5 7 p. 1538-1544
artikel
24 Preserving vascular prostacyclin levels by microsomal prostaglandin E2 synthase isoform 1 inhibition: a new strategy for vasoprotection? KRÖTZ, F.
2007
5 7 p. 1409-1410
artikel
25 Prospective evaluation of the ‘4Ts’ score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia POUPLARD, C.
2007
5 7 p. 1373-1379
artikel
26 Protein C inhibitor directly and potently inhibits activated hepatocyte growth factor activator HAYASHI, T.
2007
5 7 p. 1477-1485
artikel
27 Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibα MARTIN, C.
2007
5 7 p. 1363-1370
artikel
28 Quality of oral anticoagulant treatment and risk of subsequent recurrent thromboembolism in patients with deep vein thrombosis PRANDONI, P.
2007
5 7 p. 1555
artikel
29 Reactive site-dependent phenotypic alterations in plasminogen activator inhibitor-1 transgenic mice EREN, M.
2007
5 7 p. 1500-1508
artikel
30 Relationship between thrombin generation and international normalized ratio in patients receiving oral vitamin K antagonist therapy ALTMAN, R.
2007
5 7 p. 1552-1569
artikel
31 TALKING ABOUT… BRUTTOMESSO, G.
2007
5 7 p. 1570-1572
artikel
32 Testing for heparin-induced thrombocytopenia: are we there yet? ARNOLD, D. M.
2007
5 7 p. 1371-1372
artikel
33 The critical role of myosin IIA in platelet internal contraction JOHNSON, G. J.
2007
5 7 p. 1516-1529
artikel
34 The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel’s active metabolite SUGIDACHI, A.
2007
5 7 p. 1545-1551
artikel
35 Tissue factor around dermal vessels has bound factor VII in the absence of injury HOFFMAN, M.
2007
5 7 p. 1403-1408
artikel
36 Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia A GOUW, S. C.
2007
5 7 p. 1383-1390
artikel
37 Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study SCHELLONG, S. M.
2007
5 7 p. 1431-1437
artikel
38 von Willebrand factor A1 domain: stuck in the middle LENTING, P. J.
2007
5 7 p. 1361-1362
artikel
39 von Willebrand factor/factor VIII concentrate (Haemate® P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery LETHAGEN, S.
2007
5 7 p. 1420-1430
artikel
40 What is the clinical impact of low plasminogen activator inhibitor-1 (PAI-1) activity? A case report and study of the incidence of low PAI-1 antigen in a healthy population SANTAMARÍA, A.
2007
5 7 p. 1565-1566
artikel
                             40 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland